ResMed Inc (RMD)

Current ratio

Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Total current assets US$ in thousands 3,505,600 3,208,420 2,836,180 2,641,120 2,357,720 2,351,300 2,378,080 2,304,580 2,367,830 2,337,820 2,325,160 2,033,700 1,931,480 1,704,300 1,547,240 1,586,260 1,574,760 1,466,150 1,451,480 1,542,610
Total current liabilities US$ in thousands 1,019,120 940,516 851,960 904,079 910,655 773,030 764,073 770,802 758,533 761,691 732,714 692,659 689,299 667,265 621,064 624,158 911,766 876,541 577,335 590,853
Current ratio 3.44 3.41 3.33 2.92 2.59 3.04 3.11 2.99 3.12 3.07 3.17 2.94 2.80 2.55 2.49 2.54 1.73 1.67 2.51 2.61

June 30, 2025 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $3,505,600K ÷ $1,019,120K
= 3.44

The current ratio of ResMed Inc. demonstrates a generally stable liquidity position over the analyzed period, with some fluctuations. At the start of the period, as of September 30, 2020, the current ratio stood at 2.61, indicating that current assets were approximately 2.61 times greater than current liabilities, signifying a comfortable liquidity cushion. This ratio experienced a slight decline by December 31, 2020, decreasing to 2.51, but remained within a robust range.

Throughout 2021, the current ratio exhibited a downward trend, reaching a low of 1.67 on March 31, 2021. This could suggest a temporary reduction in liquidity or a change in the composition of current assets and liabilities. However, the ratio recovered subsequently, rising back to 2.54 by September 30, 2021, and maintaining strength through the remainder of 2021, with ratios around 2.49 to 2.55.

In 2022, the current ratio continued to improve, reaching 2.80 by June 30, and further increasing to 2.94 by September 30. This upward trend indicates enhanced liquidity and possibly better short-term asset management or controlled liabilities growth. The ratio peaked at 3.17 at the close of 2022, reflecting a solid liquidity position.

The first half of 2023 saw the ratio remaining above 3.0, with 3.07 at the end of March and 3.12 in June, suggesting strong liquidity levels. Slight fluctuations occurred, with a minor decrease to 2.99 in September 2023, but the ratio remained comfortably above typical minimum benchmarks. As of December 31, 2023, the ratio increased again to 3.11.

In early 2024, the ratio decreased slightly to 3.04 in March but then declined further to 2.59 by June 30. Nonetheless, the ratio rebounded to 2.92 as of September 30, 2024, and increased significantly through late 2024 and into 2025, reaching 3.33 in December 2024, and an even higher 3.41 as of March 31, 2025. The ratio further increased to 3.44 by June 30, 2025, indicating a consistent and healthy liquidity buffer in recent periods.

Overall, the trend of ResMed Inc.'s current ratio reflects stability with periods of fluctuation, but generally maintains a position well above the commonly accepted threshold of 1.0, indicating a prudent liquidity management approach and a strong ability to meet short-term obligations. The ratio's upward trajectory toward the latter part of the observed timeline suggests an overall strengthening of the company's liquidity position.